These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 5982622

  • 41. [Carcinogenic properties of serotinin derivatives].
    Romanenko VI, Raushenbakh MO, Zharova EI, Malakhova NV, Shteĭnpress AB.
    Patol Fiziol Eksp Ter; 1982; (5):88-91. PubMed ID: 6184669
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Occupationally conditioned bladder cancer--are the patients identified?].
    Thomsen M, Mikines KJ.
    Ugeskr Laeger; 2006 Nov 20; 168(47):4095-8. PubMed ID: 17134607
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Failure to activate Epstein-Barr virus genome in a latently-infected human lymphoblastoid cell line with urine containing a bladder carcinogenesis promoter].
    Fujita J, Yoshida O.
    Hinyokika Kiyo; 1984 Jul 20; 30(7):897-901. PubMed ID: 6095626
    [Abstract] [Full Text] [Related]

  • 49. Specific aromatic amines as occupational bladder carcinogens.
    Clayson DB.
    Natl Cancer Inst Monogr; 1981 Dec 20; (58):15-9. PubMed ID: 7341971
    [Abstract] [Full Text] [Related]

  • 50. Urinary bladder carcinogenesis.
    Cohen SM, Hasegawa R, Greenfield RE, Ellwein LB.
    IARC Sci Publ; 1984 Dec 20; (56):93-108. PubMed ID: 6536613
    [No Abstract] [Full Text] [Related]

  • 51. Bladder tumours in industry.
    Lancet; 1965 Dec 04; 2(7423):1173. PubMed ID: 4158918
    [No Abstract] [Full Text] [Related]

  • 52. [Studies on the metabolic conversion of tryptophan into nicotinic acid in individuals with tumors of the bladder. Modifications in the urinary excretory picture after the administration of nicotinamide and vitamin B6].
    SACCONE C, TANCREDI F, FEDELE L, QUAGLIARIELLO E.
    Boll Soc Ital Biol Sper; 1960 Dec 31; 36():1942-3. PubMed ID: 13745208
    [No Abstract] [Full Text] [Related]

  • 53. Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
    Headley DB, Klopp RG, Michie PM, Ertürk E, Bryan GT.
    Cancer Res; 1981 Apr 31; 41(4):1397-1401. PubMed ID: 7214326
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Dyestuffs and bladder cancer.
    Howard K.
    N Z Med J; 1993 Sep 08; 106(963):391. PubMed ID: 8367102
    [No Abstract] [Full Text] [Related]

  • 58. [The "immunoparalyzing" and "in-vivo saturating" activity of haptens of Klebsiella ozenae and Klebsiella scleromatis].
    Schivo ML, Fenu G, Atzeni A.
    Otorinolaringol Ital; 1968 Sep 08; 37(1):37-45. PubMed ID: 5719449
    [No Abstract] [Full Text] [Related]

  • 59. Rodent bladder tumors do not always predict for humans.
    Cohen SM, Lawson TA.
    Cancer Lett; 1995 Jun 29; 93(1):9-16. PubMed ID: 7600547
    [Abstract] [Full Text] [Related]

  • 60. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption.
    Young JF, Kadlubar FF.
    Drug Metab Dispos; 1982 Jun 29; 10(6):641-4. PubMed ID: 6130914
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.